Anidulafungin (Eraxis) for Candida infections

Medical Letter on Drugs and Therapeutics

Volumn 48, Issue 1235, 2006, Pages 43-44

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; RIFAMPICIN; VORICONAZOLE; ANTIFUNGAL AGENT; CYCLOPEPTIDE;

ASPERGILLUS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CANDIDIASIS; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; DRUG ACTIVITY; DYSPNEA; ESOPHAGUS CANDIDIASIS; FEVER; FLUSHING; FUSARIUM; HEPATITIS; HUMAN; HYPOKALEMIA; HYPOTENSION; IN VITRO STUDY; LIVER FAILURE; NAUSEA; NONHUMAN; PNEUMOCYSTIS JIROVECI; PRURITUS; RASH; SHORT SURVEY; SIDE EFFECT; TRICHOSPORON; URTICARIA; VOMITING; ZYGOMYCETES; ANIMAL; ARTICLE; CONTROLLED CLINICAL TRIAL; DRUG INTERACTION; HALF LIFE TIME; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG INTERACTIONS; HALF-LIFE; HUMANS; PEPTIDES, CYCLIC; RANDOMIZED CONTROLLED TRIALS;

EID: 33745487601     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Caspofungin (Cancidas) for aspergillosis. Med Lett Drugs Ther 2001; 43:58.
2. Micafungin (Mycamine) for fungal infections. Med Lett Drugs Ther 2005; 47:51.
3. M Laverdiere et al. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J Antimicrob Chemother 2006; 57:705.
4. A Philip et al. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother 2005; 49:3572.
5. M Ghannoum. Anidulafungin. Infect Dis Clin Prac 2005; 13:165.
6. MA Pfaller et al. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J Clin Microbiol 2005; 43:5425.
7. DS Krause et al. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis 2004; 39:770.
8. Anidulafungin (Eraxis) prescribing information. Pfizer, February 2006.
9. A Reboli et al. Anidulafungin vs. fluconazole for treatment of candidemia and invasive candidiasis (abstract). 45th ICAAC, Washington DC, December 16-19, 2005.
10. DK Benjamin Jr. et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother 2006; 50:632.